DR. MARCOS VINCENT MASSON, MD

HOUSTON, TX

Research Active
Orthopaedic Surgery - Hand Surgery NPI registered 21+ years 41 publications 2023 – 2026 NPI: 1134123664
Arthritis, RheumatoidPregnancyAntirheumatic AgentsGlucocorticoidsLupus Erythematosus, SystemicSeverity of Illness IndexSmokingSmoking CessationGynecologyAutoantibodiesAntibodies, Monoclonal, HumanizedFrancePregnancy ComplicationsPatient Education as TopicAntibodies, Antinuclear

Practice Location

1200 BINZ ST
HOUSTON, TX 77004-6900

Phone: (713) 520-1210

What does MARCOS MASSON research?

Dr. Masson studies the complexities of systemic lupus erythematosus, a chronic autoimmune condition, especially as it relates to concurrent conditions like fibromyalgia, and the development of effective treatments for pregnant women with lupus to protect their newborns from complications. He researches how better education can help patients, such as those with tuberculosis, understand their treatment, ultimately improving their health outcomes. Additionally, he explores methods to assist patients in quitting smoking, highlighting the critical role healthcare providers play in supporting individuals looking to improve their quality of life.

Key findings

  • In a study of 181 SLE patients, those with fibromyalgia reported significantly worse symptoms, including higher fatigue and pain intensity, even with 13% in remission.
  • A treatment using rozanolixizumab led to a 65% reduction in harmful antibodies in a pregnant woman with a history of cardiac neonatal lupus, resulting in the birth of a healthy baby.
  • Among 92 patients with rheumatoid arthritis treated with methotrexate, 88% had tibia fractures, and 91% of those who stopped methotrexate reported healing and pain relief compared to only 29% of those who continued.
  • A study on 1211 SLE patients showed that using glucagon-like peptide-1 receptor agonists resulted in a 13% weight loss after 6-10 months, with minimal disease flare-ups.
  • Research indicated that focused educational programs for tuberculosis patients significantly enhance their understanding of treatment, directly impacting disease management and outcomes.

Frequently asked questions

Does Dr. Masson study systemic lupus erythematosus (SLE)?
Yes, Dr. Masson conducts extensive research on SLE, focusing on treatment options, patient-reported outcomes, and the impact of comorbidities like fibromyalgia.
What treatments has Dr. Masson researched for lupus patients?
He has researched treatments like rozanolixizumab to prevent cardiac issues in newborns of mothers with lupus and the effects of glucagon-like peptide-1 receptor agonists for managing weight in SLE patients.
Is Dr. Masson's work relevant to tuberculosis patients?
Yes, his research aims to improve education and management strategies for tuberculosis patients, helping them understand their treatment and improve health outcomes.
How does Dr. Masson help patients who want to quit smoking?
Dr. Masson studies various methods, including tailored support from healthcare professionals, to help smokers quit effectively and improve their overall health.
What is the significance of his research on water quality and pollution?
His research on identifying and addressing pollution sources helps local communities and farmers protect their water resources, which is crucial for health and agriculture.

Publications in plain English

Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study.

2026

Annals of the rheumatic diseases

Carlucci PM, Masson M, Cuneo BF, Brandt JS, Worthing AB +6 more

Plain English
This study looked at a new treatment using a drug called rozanolixizumab to prevent heart problems in babies born to mothers with a specific type of lupus that can affect the heart (known as cardiac neonatal lupus). A 34-year-old woman with a history of this issue during her last three pregnancies received weekly doses of the drug, resulting in a significant drop in harmful antibodies by about 65% during her pregnancy. Ultimately, she delivered a healthy baby without serious complications, although the baby did develop a mild skin rash linked to neonatal lupus at five weeks old. Who this helps: This research benefits pregnant women with lupus and their babies.

PubMed

Limiting resident shifts to 16 hours is evidence informed, ethically sound.

2026

Canadian family physician Medecin de famille canadien

Masson M

PubMed

Patient-reported outcome measures in patients with systemic lupus erythematosus with or without concurrent fibromyalgia.

2026

Lupus

Gold HT, Li Y, Anthopolos R, Buyon JP, Masson M +7 more

Plain English
This study looked at patients with systemic lupus erythematosus (SLE) to see how their reported symptoms differed based on whether they also had fibromyalgia (FM). Among 181 patients, those with FM reported significantly worse symptoms, like higher fatigue and pain intensity, even though 13% were in remission. This research is important because it shows that using specific patient-reported measures can help doctors better understand and manage the severity of symptoms in SLE patients. Who this helps: This helps patients suffering from SLE, especially those also dealing with fibromyalgia.

PubMed

Corrigendum to "E6 Proteins from Diverse Papillomaviruses Self-Associate Both In Vitro and In Vivo" [J. Mol. Biol. 396(1) (2010) 90-104].

2026

Journal of molecular biology

Zanier K, Ruhlmann C, Melin F, Masson M, M'hamed Ould Sidi AO +10 more

PubMed

A retrospective evaluation of glucagon-like peptide-1 receptor agonists in systemic lupus erythematosus patients.

2025

Rheumatology (Oxford, England)

Carlucci PM, Cohen B, Saxena A, Belmont HM, Masson M +3 more

Plain English
This study looked at the effects of a type of medication called glucagon-like peptide-1 receptor agonists (GLP1-RAs) on patients with systemic lupus erythematosus (SLE). Out of 1211 patients, 18 were studied after using GLP1-RAs, and they showed a 3% weight loss after 1-4 months and a 13% weight loss after 6-10 months. Importantly, there was only one mild flare of SLE during the follow-up, indicating that the medication did not worsen the condition. Who this helps: This research helps patients with lupus who are managing their weight and considering GLP1-RAs for treatment.

PubMed

Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade.

2025

The Lancet. Rheumatology

Buyon JP, Carlucci PM, Cuneo BF, Masson M, Izmirly P +13 more

PubMed

Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial.

2025

Annals of the rheumatic diseases

Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, Salliot C +21 more

Plain English
This study looked at two ways to stop using glucocorticoid medications in patients with rheumatoid arthritis (RA) who had low disease activity. The researchers found that after a year, about 55% of those who switched to hydrocortisone and 47% of those who gradually reduced their prednisone were able to completely stop taking their medications, showing no significant difference between the two methods. This matters because it helps determine the best approach for safely discontinuing glucocorticoids, which can have side effects. Who this helps: This helps patients with rheumatoid arthritis manage their treatment effectively.

PubMed

Consumer behavior at sale point and consumption according to strawberry quality: How to use those data to evaluate food waste?

2025

Current research in food science

Pignères E, Masson M, Duret S, Blumenthal D, Gouton MA +5 more

Plain English
This study looked at how French consumers buy, store, and eat strawberries to understand food waste better. Researchers surveyed 509 people and found that food waste varies based on how strawberries are handled after purchase; if they start to spoil at the store, up to 57.5% can end up wasted at home. This matters because improving how we handle fresh produce could significantly reduce food waste, benefiting both the environment and economies. Who this helps: This helps consumers and retailers by highlighting better storage practices to minimize waste.

PubMed

[Nurses: key players in helping people to stop smoking].

2025

Revue de l'infirmiere

Perriot J, Londaitzbehere A, Masson M, Peiffer G

Plain English
This paper looks at how nurses can effectively help people quit smoking, which is a major cause of preventable deaths. It emphasizes that nurses are essential in this effort, using various techniques to support patients in different settings like hospitals and workplaces. This is important because quitting smoking can significantly improve health and reduce death rates related to smoking. Who this helps: This helps patients trying to quit smoking.

PubMed

METHOFRACT, a methotrexate osteopathy multicentre cohort study.

2025

RMD open

Robin F, Ghossan R, Mehsen-Cetre N, Triquet L, Larid G +32 more

Plain English
This study looked at a rare condition called methotrexate-induced osteopathy, which causes fractures in patients with rheumatoid arthritis or psoriatic arthritis who are treated with methotrexate. Researchers found that out of 92 patients, 88% had tibia fractures and 76% had multiple fractures at the time of diagnosis. Stopping methotrexate led to healing and pain relief for 91% of those who discontinued it, compared to only 29% who continued treatment. Who this helps: This research benefits patients with rheumatoid arthritis and psoriatic arthritis, particularly postmenopausal women at risk for fractures.

PubMed

[Support for seniors who want to quit smoking].

2025

Revue de l'infirmiere

Perriot J, Masson M, Roux A, Peiffer G

Plain English
This study looks at ways to support older adults who want to stop smoking. It found that quitting smoking can improve health and reduce risks for diseases and disabilities, no matter how old someone is. By helping seniors quit, healthcare professionals can make a significant difference in their quality of life. Who this helps: This helps older patients who want to quit smoking.

PubMed

Tracking Aeromonas caviae and Pseudomonas aeruginosa in a mixed-use catchment with source attribution, health hazards, and microbial mixing assessments.

2025

Environmental science and pollution research international

Pozzi ACM, Dominguez-Lage A, Luton B, Marjolet L, Mouniée D +13 more

Plain English
This study looked at two harmful germs that can contaminate water, Aeromonas caviae and Pseudomonas aeruginosa. It found that Aeromonas was mainly found in water from roads, and its levels were linked to pollution from humans and animals, while Pseudomonas was more common in forest streams. These findings highlight that pollution from roads and wastewater can seriously harm water quality and pose health risks to both people and animals. Who this helps: This helps patients, environmental health officials, and community planners.

PubMed

Systemic reform requires accountability.

2025

Canadian family physician Medecin de famille canadien

Masson M

PubMed

[Strengthening therapeutic education for tuberculosis patients].

2025

Revue de l'infirmiere

Perriot J, Masson M, Peiffer G

Plain English
This study looked at how improving education for tuberculosis patients can help manage the disease better. Researchers found that focused educational programs can significantly enhance patients’ understanding of their treatment, leading to better health outcomes. This matters because it can reduce the disease's spread and lower death rates among those affected. Who this helps: This helps patients with tuberculosis and healthcare providers managing their care.

PubMed

Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases.

2024

Rheumatology (Oxford, England)

Thomas M, Masson M, Bitoun S, Hamroun S, Seror R +5 more

Plain English
This study looked at how well the drug combination tixagevimab/cilgavimab works to prevent COVID-19 in patients with autoimmune diseases who don’t respond well to vaccines. Out of 115 patients, only 20% got COVID-19, which is lower than the general population rate of about 1,071 per 100,000 people. Those who received two doses instead of one had a significantly lower infection rate (8% vs. 33%). Who this helps: This benefits patients with autoimmune diseases who are at high risk for severe COVID-19.

PubMed

Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.

2024

Arthritis & rheumatology (Hoboken, N.J.)

Buyon JP, Masson M, Izmirly CG, Phoon C, Acherman R +35 more

Plain English
This study looked at pregnant women with specific antibodies (anti-SSA/Ro) to see how well heart monitoring could detect a rare heart condition in their babies called atrioventricular block (AVB). Out of 413 participants, 63% had high levels of these antibodies, and 3.8% of them developed AVB, with the chances rising to 27.3% for those with a previous child who had the condition. The findings are important because they suggest that careful monitoring of fetal heart rates can help catch potential heart issues early while reducing the need for extra ultrasounds. Who this helps: This benefits pregnant patients with anti-SSA/Ro antibodies and their healthcare providers.

PubMed

Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry.

2024

The Journal of infection

Caillet Portillo D, Puéchal X, Masson M, Kostine M, Michaut A +25 more

Plain English
This study looked at how Tropheryma whipplei infection affects patients who have inflammatory rheumatic disease, which can sometimes be mistaken for that condition itself. Among 73 patients, it was found that 93% achieved remission from their inflammatory symptoms after being treated for the infection with antibiotics, allowing many to stop other medications they were taking. This matters because identifying and treating this infection can lead to significant improvement for patients who may have been misdiagnosed or inadequately treated for their rheumatic disease. Who this helps: Patients with inflammatory rheumatic disease who may have Tropheryma whipplei infection.

PubMed

Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia.

2024

ACR open rheumatology

Corbitt K, Carlucci PM, Cohen B, Masson M, Saxena A +6 more

Plain English
This study looked at how fibromyalgia (FM) affects patients with systemic lupus erythematosus (SLE), a type of autoimmune disease. Out of 316 SLE patients, 55 (17.4%) were found to have FM, with more active arthritis reported in the FM group (16.4%) compared to just 1.9% in those without FM. This research highlights the need to better understand the connection between FM and SLE, as many symptoms do not differ significantly between the two groups. Who this helps: This benefits patients with SLE and FM by improving understanding and management of their conditions.

PubMed

Reply.

2024

Arthritis & rheumatology (Hoboken, N.J.)

Buyon J, Izmirly P, Masson M, Carlucci P, Izmirly CG +2 more

PubMed

The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanisms.

2024

Cancer letters

Riegel G, Orvain C, Recberlik S, Spaety ME, Poschet G +9 more

Plain English
This study looked at a new compound called RDC11, which is designed to treat gastric cancer by overcoming resistance to traditional platinum-based therapies. Researchers found that RDC11 killed cancer cells more effectively than oxaliplatin, a common treatment, and slowed tumor growth in animal models. This is important because it offers a promising alternative for patients who do not respond well to current treatments due to specific genetic changes. Who this helps: This helps patients with gastric cancer who are resistant to standard treatments.

PubMed

Tracing endogenous proteins in living cells through electrotransfer of mRNA encoding chromobodies.

2024

Biotechnology journal

Juncker T, Richert L, Masson M, Zuber G, Chatton B +1 more

Plain English
This research studied a new method for tracking proteins inside living cells using special tools called chromobodies. By using mRNA (the genetic material that carries instructions for making proteins) instead of plasmids, researchers could better control how many chromobodies were produced inside the cells, leading to clearer imaging results. They tested this method on three different proteins and found that it accurately tracked their locations, improving live-cell imaging. Who this helps: This helps researchers and scientists studying cell biology and protein functions.

PubMed

[The shared educational assessment in the smoking cessation process].

2024

Revue de l'infirmiere

Peiffer G, Masson M, Perriot J, Underner M, Rouquet RM

Plain English
This study looked at a method called the shared educational assessment (BEP) that helps people quit smoking by identifying their specific needs and goals. Researchers found that using BEP improves the chances of smokers staying smoke-free, as it leads to tailored support and workshops. This matters because personalized guidance can make quitting smoking more effective, ultimately leading to better health outcomes for individuals. Who this helps: Patients trying to quit smoking.

PubMed

Pharmacological and nutraceutical treatments for borderline personality disorder.

2024

L'Encephale

Gérolymos C, Boyer L, Masson M, Fond G

PubMed

Identifying sources and distribution of organic pollutants in a Moroccan river: Characterization of dissolved organic matter by absorption, excitation-emission fluorescence and chemometric analyses.

2024

Journal of hazardous materials

Ba-Haddou H, Taoussi O, Ait Lyazidi S, Coquery M, Masson M +3 more

Plain English
This study looked at pollution in the Ben-Kazza River in Morocco, which is affected by wastewater from a nearby treatment plant and industrial waste. Researchers analyzed 495 water samples and found that the treatment plant was effective at removing some types of organic pollutants, reducing specific harmful indicators by up to 68%. Understanding the sources and types of pollution in the river is vital for protecting water quality, which is important for both the environment and human health. Who this helps: This research benefits local communities and farmers who rely on clean water for irrigation and health.

PubMed

[The role of vaping in smoking cessation].

2024

Revue de l'infirmiere

Peiffer G, Masson M, Perriot J

Plain English
This study looked at how well vaping helps people quit smoking. It found that electronic cigarettes can be an effective tool for quitting, with many users able to reduce or stop their tobacco use. Understanding the best ways to use vaping can help improve smoking cessation efforts. Who this helps: This benefits smokers trying to quit and healthcare providers advising them.

PubMed

Evaluation and randomised controlled trial of home urinalysis testing in patients with SLE at elevated risk for developing lupus nephritis: a study protocol.

2024

Lupus science & medicine

Gold HT, El Shahawy O, Izmirly PM, Masson M, Cohen B +1 more

Plain English
This study looked at how home urinalysis testing can help patients with systemic lupus erythematosus (SLE) who are at high risk of developing kidney disease. Researchers found that timely home testing could identify kidney problems earlier, potentially helping doctors diagnose issues before they become severe. The study plans to include 160 participants and aims to determine whether weekly urine tests can detect kidney damage sooner than regular care does, which could lead to better health outcomes. Who this helps: This benefits patients with SLE, especially those at risk for lupus nephritis.

PubMed

[Eat well to live well: Is psychonutrition ready for clinical practice in mental health?].

2024

L'Encephale

Fond G, Masson M

PubMed

Sampling terrigenous diffuse sources in watercourse: Influence of land use and hydrological conditions on dissolved organic matter characteristics.

2023

The Science of the total environment

Boukra A, Masson M, Brosse C, Sourzac M, Parlanti E +1 more

Plain English
This study looked at how different land uses, like forests and vineyards, affect the characteristics of dissolved organic matter in streams. Researchers found that during the first three days of their experiment, up to 70% of the dissolved organic carbon was lost from soil extracts. They discovered that the dissolved organic matter in water was influenced not only by the type of land but also by the water levels, showing that sampling at different times can give a better picture of what’s in the water. Who this helps: This helps environmental scientists and water quality managers understand and track the impact of land use on water ecosystems.

PubMed

Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair.

2023

Theranostics

Bruyere D, Roncarati P, Lebeau A, Lerho T, Poulain F +16 more

Plain English
This study looked at how specific proteins from the human papillomavirus (HPV) influence the way cancer cells respond to radiation therapy. Researchers found that just one of these proteins, E6 or E7, can make cancer cells more sensitive to radiation without harming their normal function. They identified 10 proteins targeted by E6 and 11 by E7, which play key roles in how cells repair DNA damage, suggesting that targeting these proteins could improve cancer treatment effectiveness. Who this helps: This helps cancer patients receiving radiation therapy, particularly those with HPV-related cancers.

PubMed

The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells.

2023

mSphere

Taverniti V, Krynska H, Venuti A, Straub ML, Sirand C +9 more

Plain English
This study looked at how a specific variant of the p73 protein, called ΔNp73α, works with another protein complex to influence gene expression in cells related to certain cancers. The researchers found that ΔNp73α interacts with the E2F4/p130 complex, and together they inhibit genes that normally help control cell growth, which could lead to more aggressive cancer behavior. This matters because understanding these interactions might help develop new treatments for cancers linked to HPV and other viruses. Who this helps: This research benefits cancer patients, particularly those with HPV-related cancers.

PubMed

Clogging modulates the copper effects on microbial communities of streambed sediments.

2023

Ecotoxicology (London, England)

Kergoat L, Dabrin A, Masson M, Datry T, Bonnineau C

Plain English
This study looked at how two factors—clogging in streambed sediments and copper pollution—affect tiny organisms living in the water-saturated areas beneath riverbeds. Researchers found that while clogging did not change how much copper was present, it did boost the activity of these microorganisms in the top layers of sediment. In contrast, copper only slightly affected some microbial functions, suggesting the top layers are more lively and diverse compared to deeper layers that are less impacted. Who this helps: This research helps environmental scientists and water management authorities better understand how pollution and sediment conditions affect river ecosystems.

PubMed

Cutaneous neonatal lupus in patients with skin of color: A retrospective cohort study from a national registry.

2023

Journal of the American Academy of Dermatology

Kleitsch J, Mazori DR, Masson M, Izmirly PM, Saxena A +2 more

PubMed

Contribution of S100A4-expressing fibroblasts to anti-SSA/Ro-associated atrioventricular nodal calcification and soluble S100A4 as a biomarker of clinical severity.

2023

Frontiers in immunology

Firl CEM, Halushka M, Fraser N, Masson M, Cuneo BF +3 more

Plain English
This study looked at a specific type of cell, called S100A4-expressing fibroblasts, in the hearts of babies affected by a condition linked to maternal antibodies. Researchers found that these cells were present in areas of heart damage but not in fibrotic areas, and that higher levels of S100A4 in the blood of affected babies were associated with more severe heart problems. This is important because it indicates that S100A4 could serve as a useful indicator of how serious the condition is in newborns, potentially guiding treatment decisions. Who this helps: This finding can benefit doctors treating babies with neonatal lupus.

PubMed

Cannabidiol (CBD) in psychiatric clinical practice: Current data.

2023

L'Encephale

Fond G, Muller T, Masson M, Boyer L

PubMed

[Pelvic exam in gynecology and obstetrics: Guidelines for clinical practice].

2023

Gynecologie, obstetrique, fertilite & senologie

Deffieux X, Rousset-Jablonski C, Gantois A, Brillac T, Maruani J +37 more

Plain English
This study focused on creating guidelines for pelvic exams in gynecology and obstetrics by consulting a panel of 45 experts. They developed 27 recommendations on when pelvic exams should be done, with strong support for 17 of those recommendations based on solid evidence. These guidelines help clarify the importance of pelvic exams in specific situations for both symptomatic and asymptomatic women, improving patient care. Who this helps: This helps healthcare providers and patients in gynecology and obstetrics.

PubMed

The modifying influence of HLA class II DQB1∗06:02 on theand clinical phenotype correlation among anti-Ro+ mothers of children with neonatal lupus.

2023

Genes & diseases

Clancy RM, Guthridge CJ, Marion MC, Guthridge J, Howard TD +5 more

PubMed

Nano-based formulations of curcumin: elucidating the potential benefits and future prospects in skin cancer.

2023

Biomedical materials (Bristol, England)

Ratan C, Arian AM, Rajendran R, Jayakumar R, Masson M +1 more

Plain English
This study looked at the potential of curcumin, a compound from the turmeric spice, as a treatment for skin cancer. It found that new nano-based forms of curcumin, such as nanogels and nanoemulsions, can improve the delivery and effectiveness of curcumin in fighting cancer cells. This is important because traditional treatments for skin cancer often come with severe side effects, and curcumin offers a safer, less expensive alternative that could enhance patients' quality of life. Who this helps: This helps skin cancer patients seeking effective and safer treatment options.

PubMed

Linking emotional valence and anxiety in a mouse insula-amygdala circuit.

2023

Nature communications

Nicolas C, Ju A, Wu Y, Eldirdiri H, Delcasso S +10 more

Plain English
This study looked at how certain brain cells in mice respond to feelings of anxiety and different types of emotional experiences (both positive and negative). Researchers found that specific neurons in the anterior insular cortex become more active when mice are in stressful situations, and this activity increases with higher anxiety levels. Understanding how these brain connections work is important because it may lead to insights on the biological basis of anxiety disorders. Who this helps: This helps researchers and doctors working to treat anxiety in humans.

PubMed

Pelvic exam in Gynecology and Obstetrics: French Guidelines for Clinical Practice.

2023

European journal of obstetrics, gynecology, and reproductive biology

Deffieux X, Pizzoferrato AC, Gaucher L, Rousset-Jablonski C, Le Ray C +37 more

PubMed

Effectiveness of School-Based Interventions in Europe for Promoting Healthy Lifestyle Behaviors in Children.

2023

Children (Basel, Switzerland)

Drouka A, Brikou D, Causeret C, Al Ali Al Malla N, Sibalo S +8 more

Plain English
This study looked at various school programs in Europe aimed at encouraging healthy habits in children aged 6 to 10. The findings showed that programs focusing on diet and physical activity led to improvements in children's health, including better eating habits and more physical activity. Successful programs typically lasted one school year and involved teachers being trained and parents participating actively. Who this helps: This benefits children and their families by promoting healthier lifestyles.

PubMed

In gratitude for the collaborative partnership with David E. Minnikin.

2023

Tuberculosis (Edinburgh, Scotland)

Váradi OA, Marcsik A, Masson M, Molnár E, Pap I +3 more

PubMed

Frequent Co-Authors

Jill P Buyon Peter Izmirly Amit Saxena Philip M Carlucci Jean Perriot Gérard Peiffer Brooke Cohen Peter M Izmirly Bettina F Cuneo Nicola Fraser

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.